Tumor cells can act with the immune checkpoint Programmed Cell Death Protein 1 (PD-1) to suppress T cell function to evade Immunosurveillance (Chen and Mellman, 2013; O Donnell et al., 2019). This evidence concerns the gene PDCD1 and neoplasm.